ClinicalTrials.gg
CompletedNCT05042323Updated May 16, 2023

Short-term Intervention and Health Trajectories After Mass Trauma

An interventional study of TF-CBT-Short in Post Traumatic Stress Disorder, sponsored by Norwegian Center for Violence and Traumatic Stress Studies. Completed at 1 site in Norway. Open to participants aged 6 Years to 19 Years. Per ClinicalTrials.gov, last updated 2023-05-16.

Sponsored by Norwegian Center for Violence and Traumatic Stress Studies · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
6 Years to 19 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Stress Disorders, Post-Traumatic by Norwegian Center for Violence and Traumatic Stress Studies — 2 open to participants now, 2 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Norwegian Center for Violence and Traumatic Stress Studies.

Started
2021
the only one that year
No phase
7 of 12
2 open now
Registered
7th of 12
by date

Among the 12 studies in Stress Disorders, Post-Traumatic by Norwegian Center for Violence and Traumatic Stress Studies, this one is the only one that started in 2021, is one of 7 with no phase, and was the 7th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

2 of the 12 studies in Stress Disorders, Post-Traumatic by Norwegian Center for Violence and Traumatic Stress Studies are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 6 Years to 19 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Stress Disorders, Post-Traumatic by Norwegian Center for Violence and Traumatic Stress Studies, or all of them as a file.
02

Study summary

This study has two aims. The first is to understand more of what may be typical health trajectories after mass trauma for children and adults and what predicts these trajectories. The second is to understand what may be effective early interventions to prevent long-term health and psychosocial problems for youth (6-19). Participants are recruited from an outreach program implemented after a landslide killed 11 persons and destroyed 33 houses in Gjerdrum in Norway. One third of the inhabitants were evacuated. All evacuated are contacted and screened for trauma related difficulties. Those who have significant post-trauma reactions are offered trauma focused interventions.

Read the detailed description

Two short step-wise interventions are developed for this study as an early intervention after mass trauma based on components from TF-CBT to test the relative importance of dosage and the sequencing of components.

03

Conditions studied

  • Post Traumatic Stress Disorder
04

Who can participate

Ages eligible
6 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Exposed to the landslide
  • Between 6-19 years old
  • A score of 15 or more on the CATS
  • A score between 11 - 14 on the CATS and have additional problems that have started or worsened after the landslide.

Exclusion criteria

Exclusion Criteria:

  • Suicidal
  • Psychotic
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    TF-CBT-Skills

    Step 1: 4-5 sessions with stabilization/skill building Step 2: 4-5 sessions with narrative and cognitive processing

    Behavioral: TF-CBT-Short

  • Active comparator
    TF-CBT-Narr

    Step 1: 4-5 sessions with narrative and cognitive processing Step 2: 4-5 sessions with stabilization/skill building

    Behavioral: TF-CBT-Short

Interventions

  • BehavioralTF-CBT-Short

    Participants receive either 4-5 sessions of TF-CBT-Skills or TF-CBT-Narr. If the participant still has significant PTSS they are provided with step two which is the components provided in the arm they did not receive.

06

What researchers measure

Primary outcomes

  1. PTSD

    Measured with the Child and adolescent trauma screen (CATS). Range 0-60. Higher score means worse outcome.

    Time frame: Pre-treatment

  2. PTSD

    Measured with the CATS (after 4-5 sessions)

    Time frame: After 5 weeks

  3. PTSD

    Measured with the CATS (for those who continue to Step two)

    Time frame: After 9 weeks

  4. PTSD

    Measured with the CATS

    Time frame: After 21 weeks

  5. PTSD

    Measured with the CATS

    Time frame: After 33 weeks

  6. PTSD

    Measured with the CATS

    Time frame: After 45 weeks

  7. PTSD

    Measured with the CATS

    Time frame: After 57 weeks

Secondary outcomes

  1. Depression

    Measured with Moods and feelings questionaire (MFQ-short). Range 0-13. Higher scores means worse outcome.

    Time frame: Pre-treatment

  2. Depression

    Measured with MFQ-short

    Time frame: After 5 weeks

  3. Depression

    Measured with MFQ-short

    Time frame: After 9 weeks

  4. Depression

    Measured with MFQ-short

    Time frame: After 21 weeks

  5. Depression

    Measured with MFQ-short

    Time frame: After 33 weeks

  6. Depression

    Measured with MFQ-short

    Time frame: After 45 weeks

  7. Depression

    Measured with MFQ-short

    Time frame: After 57 weeks

Other outcomes

  1. Anxiety

    Measured with Screen for Child Anxiety Related Emotional Disorders (SCARED-5 Item)

    Time frame: Pre-treatment

  2. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 5 weeks

  3. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 9 weeks

  4. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 21 weeks

  5. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 33 weeks

  6. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 45 weeks

  7. Anxiety

    Measured with SCARED-5 Item

    Time frame: After 57 weeks

07

Study locations

1 site
  • Norwegian center for violence and traumatic stress studies
    Oslo, Norway
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Aug 2022, 16 months.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 16 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 14, 2021
First posted
Sep 13, 2021
StartActual
Mar 15, 2021
Primary completionActual
Aug 1, 2022
CompletionActual
Mar 15, 2023
Last update
May 16, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05042323
Lead sponsor
Norwegian Center for Violence and Traumatic Stress Studies
Responsible party
Sponsor
First posted
Sep 13, 2021
Start date
Mar 15, 2021
Primary completion
Aug 1, 2022
Completion
Mar 15, 2023
Last update
May 16, 2023

Study contacts

Tine K Jensen, PhD
principal investigator · Norwegian Center for Violence and Traumatic Stress Studies

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion